TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
NKTX

Nkarta Inc

Healthcare · Biotechnology

2.80$ -3.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement NKTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% – – – – –
64.9% 14.9% 272,207.8% – – – – –
35.1% 85.1% -272,207.8% – – – – –
64.9% 14,921.3% 9,407,792.2% – – – – –
40.5% 4,547.4% 3,970,909.1% – – – – –
105.4% 19,468.7% 13,378,701.3% – – – – –
-5.4% -19,368.7% -13,378,701.3% – – – – –
0.0% 409.9% 81,298.7% – – – – –
-4.2% -18,265.7% -23,730,129.9% – – – – –
1.3% 1,567.0% -10,636,883.1% – – – – –
-4.2% -18,265.7% -23,730,129.9% – – – – –
-1.4% -17,376.4% -13,174,545.5% – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?